MeSH D012220 - rhinitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Pseudoephedrine, TRIPROLIDINE | Triphed |  | 1984-05-17 |  |  |
| Pseudoephedrine, TRIPROLIDINE | Triprolidine Pseudoephedrine |  | 1984-12-12 |  |  | |
| Taro Pharmaceutical | Oxymetazoline | Oxymetazoline |  | 2021-10-04 |  |  |
| Xiromed | Ephedrine | Ephedrine |  | 2022-04-21 |  |  |
| Johnson & Johnson | Oxymetazoline | Visine |  | 1989-03-31 |  |  |
| GSK | Pseudoephedrine, Codeine, TRIPROLIDINE | Actifed |  | 1984-04-04 |  |  |
| Sandoz | Ephedrine | Ephedrine |  | 2017-08-23 |  |  |
| Pseudoephedrine, TRIPROLIDINE | Pseudoephedrine Triprolidine |  | 1983-05-17 |  |  | |
| Novartis | Chlorpheniramine, Phenylpropanolamine | Triaminic |  | 1982-01-01 |  |  |
| Alpharma | Hydrocodone, Phenylpropanolamine | Codamine |  | 2000-09-29 |  |  |
| Allergan | Pseudoephedrine, TRIPROLIDINE | Triprolidine Pseudoephedrine |  | 1984-01-13 |  |  |
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
100%7/7
Phase 2
57%8/14
Phase 3
41%13/32
Approved: 5Overall Success rate: 23%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use